The father of Alice (in Wonderland) was Henry George Liddell (1811-98), a skyrocket of a Victorian public figure who headed ...

Need a little help understanding the Gen Alpha kids? You’re not alone, according to a new ranking of the most Googled slang ...

Need a little help understanding the Gen Alpha kids? You’re not alone, according to a new ranking of the most Googled slang ...

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Lexicon Pharmaceuticals LXRX in the last three months. The following table summarizes their ...

Eventually, nine muses were identified, covering every branch of the arts, in the ancient Greek poet Hesiod’s introduction to Theogony, his epic poem about mythical stories and characters (circa ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report), with a price target of $10.00. The company’s shares ...

The partnership is set to capitalise on Viatris’ extensive global reach and expertise in the cardiovascular sector. Credit: Jo Panuwat D/Shutterstock. Lexicon Pharmaceuticals has entered a licensing ...

The deal is a boost to Lexicon, because the company was unlikely to try to sell Inpefa outside of the U.S. on its own, according to Jefferies’ Tsai. Meanwhile, the drug fits into plans by Viatris to ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Lexicon Pharmaceuticals is selling rights to its only marketed drug outside of the U.S. and Europe amid a ...

(Nasdaq: VTRS), a global healthcare company, today announced it has entered into an exclusive licensing agreement with Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) for sotagliflozin in all markets ...